Leishmaniases: Epidemiological Report in the Americas, No. 2 (June 2014)
MetadataShow full item record
[Presentation]. The strengthening health surveillance of leishmaniases in the Americas is one of the goals of the Regional Program of Leishmaniases of the Pan American Health Organization - World Health Organization (PAHO-WHO), which together with the Member States has been working actively in this regard. In 2013, we implemented a Regional Information System for Leishmaniases - SisLeish - whose purpose is to aggregate and consolidate data on descriptive variables and occurrence of leishmaniases in the region and to provide epidemiological information to managers and health professionals when making decisions. From 2012, through a joint effort of the National and Regional Programs of Leishmaniases, variables and epidemiological and operational indicators were standardized to perform the analysis of interest. At the Regional Meeting of Leishmaniases Programs-RepLeish- held in October 2013, the SisLeish was presented and discussed, and an annual schedule to add data to the system was established.
Table of contents
Presentation | Epidemiological status: Cutaneous and mucosal leishmaniases; Visceral leishmaniasis | Final remarks | Acknowledgements
Category of PAHO Strategic Plan 2014-2019
Showing items related by title, author, creator and subject.
Pan American Health Organization; Communicable Diseases and Environmental Determinants of Health (CDE) (Washington, D.C., PAHO, 2020-12-03)In the Americas, leishmaniasis are a public health problem due to their magnitude and geographic distribution and because they produce clinical forms that can cause death, disability, and mutilation. In recent years, the ...
Pan American Health Organization (Washington, D.C., PAHO, 2016-07)[Introduction]. The leishmaniases are vector-borne diseases with a zoonotic cycle in the Americas and remain a problem to public health. This disease presents a high burden capable of yielding severe clinical forms that ...
Pan American Health Organization (Washington, D.C., PAHO, 2017-04)[Introduction]. In the Americas, leishmaniases remain a public health problem due to their magnitude and clinical, biological and epidemiological complexity, mainly affecting the poorest, especially in developing countries, ...